Animal Health Solution - a Covetrus magazine for veterinary professionals
Issue link: https://www.e-digitaleditions.com/i/1535882
15 Spring 2025 | Animal Health Solutions The struggle is real: The difficulty with traditional medications Many dog owners hide the fact that they struggle to administer conventional tablet medications. One survey showed that 65% of pet owners with itchy dogs reported challenges associated with typical tablet-based therapies. 1 The challenges with pilling may vary and can lead to negative outcomes for the dog, owner, and the veterinary health care team. The consequences of clients struggling to medicate their itchy dogs may include: decreased owner compliance, decreased treatment efficacy, higher owner injury risk, a sense of owner helplessness and frustration, and handling associated stress and medication aversion for the dog. This emotional toll is significant, with 29% of dog owners reporting that they feel almost constantly or frequently stressed or unhappy about their difficulties with conventional therapies. 1 The effects on owners whose itchy pets require daily long-term medication are concerning. 5 "Whys" pets and owners prefer chewable medications So, what can a chewable formulation overcome? The possibilities are numerous based on pet owner surveys, testimonials, and case studies. Here are five reasons why Apoquel Chewable can simplify and improve the itchy dog journey from the immediate need to treat the allergic itch, to the initial diagnosis, to the need for ongoing anchor therapy. 1 | Easy administration in pets Medication compliance is a well-known challenge in human and veterinary medicine, with pill administration a unique barrier for dog owners. Daily medication administration can place surprising demands on the pet owner's time - in a study, 63% of dog owners disguised conventional tablet-based therapies with food to ensure their itchy dog accepted the medication — and 30% of dog owners built extra time into their day, or interrupted their daily routine, to administer the tablet. 1 These small inconveniences can potentially lead to inconsistent dosing of their itchy dog or discontinued treatment. Apoquel Chewable's high palatability and treat-like formulation may increase the dog's cooperation with treatment — dogs voluntarily accepted 91.6% of Apoquel Chewable doses 2 — and decrease the owner's stress and time investment. 2 | Efficacy for pets In addition to its simpler administration, Apoquel Chewable is as effective as the Apoquel tablet formulation in providing fast, effective relief that begins to control the itch within 4 hours when caused by atopic and allergic dermatitis after the first dose. 3 The rapid and visible improvement in the dog's clinical signs of allergic itch may increase the client's trust and confidence in the medication, which encourages continued use. Given 70% of pet owners surveyed preferred Apoquel Chewable over Apoquel tablet after reviewing their product profiles, these additional benefits of Apoquel Chewable may lead to better medication adherence and greater long-term efficacy. 1

